Home › Ulcerative Colitis › Washington › Tacoma
Pag-aaral pangklinika para sa Ulcerative Colitis sa Tacoma, WA
Isang pag-aaral para sa Ulcerative Colitis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tacoma. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Site US-029, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Nagre-recruitPhase 2
- Digestive Health Specialists, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Nagre-recruitPhase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Washington Gastroenterology - Tacoma, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- GI Alliance Tacoma, Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Nagre-recruitPhase 2
- Site 019, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Nagre-recruitObservasyonal na pag-aaral
- Washington Gastroenterology, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Nagre-recruitPhase 2/3
- MultiCare Health System, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Nagre-recruitPhase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Nagre-recruitPhase 3
- MultiCare Institute for Research & Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Nagre-recruitPhase 2
- Mirador Therapeutics Selected Site, Tacoma
Pag-aaral para sa Ulcerative Colitis sa ibang lungsod
- Orlando, FL21 pag-aaral
- New York City, NY21 pag-aaral
- Miami, FL20 pag-aaral
- Houston, TX14 pag-aaral
- San Diego, CA13 pag-aaral
- Chicago, IL13 pag-aaral
- St. Louis, MO13 pag-aaral
- Tyler, TX13 pag-aaral
- San Antonio, TX13 pag-aaral
- Colorado Springs, CO12 pag-aaral
- Boston, MA12 pag-aaral
- Los Angeles, CA11 pag-aaral
Iba pang pag-aaral sa Tacoma
- Non-Small Cell Lung Cancer18 pag-aaral
- Kanser sa Suso17 pag-aaral
- Multiple Myeloma13 pag-aaral
- Kanser sa Prostate11 pag-aaral
- Metastatic Cancer10 pag-aaral
- Crohn's Disease10 pag-aaral
- Colorectal Cancer10 pag-aaral
- Kanser sa Ovary7 pag-aaral
- Melanoma7 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- Kanser sa Tiyan6 pag-aaral
- Kanser sa Pancreas6 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.